Arondite | $12,000,000 | (May 2, 2025)
SafeHeal | $39,548,022 | (May 2, 2025)
Ceto | $4,800,000 | (May 2, 2025)
Certified by Founder
Lodge
RheumaGen
start up
United States
- Denver, Colorado
- 10/01/2025
- Series A
- $15,000,000
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.
- Industry Biotechnology Research
- Website https://www.rheumagen.com/
- LinkedIn https://www.linkedin.com/company/rheumagen/
Peek(US) | $5,000,000 | (May 2, 2025)
Paramark.com | $8,000,000 | (May 2, 2025)
Zoe Financial | $30,000,000 | (May 2, 2025)
Stately Bio | $12,000,000 | (May 2, 2025)
SatLeo Labs | $3,300,000 | (May 2, 2025)
QbDVision | $13,000,000 | (May 2, 2025)
Blacksmith | $3,500,000 | (May 2, 2025)
Manifest | $15,000,000 | (May 1, 2025)
Persona | $200,000,000 | (May 1, 2025)